Tenax Therapeutics Inc (NASDAQ: TENX) kicked off on Monday, up 11.49% from the previous trading day, before settling in for the closing price of $11.05. Over the past 52 weeks, TENX has traded in a range of $4.63-$14.22.
During the last 5-year period, the sales growth of Healthcare Sector giant was 77.86%. While this was happening, its average annual earnings per share was recorded -19.37%. With a float of $4.79 million, this company’s outstanding shares have now reached $5.91 million.
Tenax Therapeutics Inc (TENX) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Tenax Therapeutics Inc is 23.35%, while institutional ownership is 87.90%. The most recent insider transaction that took place on Dec 09 ’25, was worth 25,542. In this transaction Chief Medical Officer of this company bought 2,500 shares at a rate of $10.22, taking the stock ownership to the 5,266 shares. Before that another transaction happened on Dec 08 ’25, when Company’s Chief Medical Officer bought 2,500 for $10.10, making the entire transaction worth $25,250. This insider now owns 5,000 shares in total.
Tenax Therapeutics Inc (TENX) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.18 earnings per share (EPS), higher than consensus estimate (set at -0.43) by 0.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -19.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -27.39% during the next five years compared to 77.86% growth over the previous five years of trading.
Tenax Therapeutics Inc (NASDAQ: TENX) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -2.75 in one year’s time.
Technical Analysis of Tenax Therapeutics Inc (TENX)
Looking closely at Tenax Therapeutics Inc (NASDAQ: TENX), its last 5-days average volume was 0.19 million, which is a drop from its year-to-date volume of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 23.49%.
During the past 100 days, Tenax Therapeutics Inc’s (TENX) raw stochastic average was set at 77.38%, which indicates a significant increase from 50.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.16 in the past 14 days, which was higher than the 0.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.25, while its 200-day Moving Average is $6.90. However, in the short run, Tenax Therapeutics Inc’s stock first resistance to watch stands at $13.53. Second resistance stands at $14.73. The third major resistance level sits at $15.62. If the price goes on to break the first support level at $11.44, it is likely to go to the next support level at $10.55. Now, if the price goes above the second support level, the third support stands at $9.35.
Tenax Therapeutics Inc (NASDAQ: TENX) Key Stats
The company with the Market Capitalisation of 76.92 million has total of 6,244K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -17,600 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -15,800 K.
